| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6183289 | Gynecologic Oncology | 2014 | 5 Pages |
Abstract
An objective measure of treatment success meaningful to survivors, physicians and regulators is, at present, elusive and may not exist. Ideally, future trial design would place equal weight on quantitative and qualitative measures and include information about goals of treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Melissa K. Frey, Sarah R. Philips, Julia Jeffries, Andrea J. Herzberg, Gwen L. Harding-Peets, Judith K. Gordon, Lorraine Bajada, Annie E. Ellis, Stephanie V. Blank,